4
Tetrahedron Letters
Conclusion
In summary, we have synthesized a series of indene-fused 4-
methylcoumarin derivatives including four indeno[1,2-
g]coumarins 1-3 and 13 together with two indeno[2,1-
g]coumarins 4 and 14 via the Pechmann condensation. An
unexpected rearrangement reaction that gave rise to the formation
of a pair of isomers was observed. The competition between the
thermodynamically and kinetically controlled reactions under
different reaction conditions resulted in various molar ratios of
the isomers. Structures of the fused coumarins were confirmed
with NMR and HRMS. X-ray crystallography was used to
identify the isomers. Photophysical and photochemical studies
found that the structurally rearranged coumarins have red shifted
absorption maxima and higher quantum yields in comparison to
their counterparts. Further investigations regarding the
application of these novel indene-fused 4-methylcoumarins as
photoremovable protecting groups are underway in our group.
Acknowledgments
Figure 3. Photophysical and photochemical properties of 3 and 4 in different
solvents: (a) Absorption spectra of 3; (b) Emission spectra of 3; (c)
Absorption spectra of 4; (d) Emission spectra of 4. Insets: normalized
emission spectra. CyH = cyclohexane, Et2O = diethyl ether, DCM =
dichloromethane, EA = ethyl acetate, ACN = acetonitrile, DMSO = dimethyl
sulfoxide.
We would like to thank the Science and Technology Bureau
of Chengdu Municipal Government (Grant 2016-XT00-00023-
GX) and the Research Foundation of SIIA Jinhua Branch (Grant
SIIAJH-201902) for financial support.
obtained coumarins were characterized (Fig. 2). Coumarins 1-3
and 13 showed similar absorption behaviours in dichloromethane.
They have a strong absorption maximum at about 270 nm and a
broad shoulder with a maximum around 350 nm. In terms of
isomers 4 and 14, the plotted spectra exhibited relatively broad
absorption bands that cover from 300 nm to 400 nm with a
maximum at about 354 nm, i.e. the absorption shoulders of non-
rearranged coumarins are the absorption maxima of the isomers.
Although the absorption properties of the isomers are quite
different to the non-rearranged coumarins, their emission
properties are similar. As shown in Figure 2b, the emission
maxima of these fused coumarins are located between 400 nm
and 440 nm. The solvent effects on the absorption and emission
spectra of isomers 3 and 4 were studied (Fig. 3). Coumarin 3 has
a maximum absorption at 268 nm and a small shoulder peak at
276 nm in cyclohexane (CyH). However, the maximum
absorption red-shifted to 279 nm with a small shoulder peak at
273 nm when 3 was characterized in dimethyl sulfoxide (DMSO).
It seems that the positions of the absorption peak and the
shoulder peak have switched with each other. The absorption
spectrum of isomer 4 measured in CyH exhibited two major
peaks at 351 nm and 369 nm, respectively, as well as a minor
peak at 360 nm. With the increase in solvent polarity, the minor
peak diminished quickly; the shoulder peak at a longer
wavelength also decreased and finally weakened into a small
shoulder peak in DMSO (Fig. 3c). A bathochromic shift of the
fluorescence emission spectra with increasing solvent polarity
was observed in both compounds 3 (Fig. 3b) and 4 (Fig. 3d).
Fluorescence quantum yields (QYs) of the fused coumarins
were measured, and the data are summarized in Table 2.
Compound 1 and 2 have QYs of 2.0 and 3.3, respectively. The
heavy atom effect of bromine might be responsible for the slight
decrease of the QY of compound 1 in comparison to compound 2.
Compound 3 has a higher QY of 10.4 due to the presence of an
electron-donating methoxy group. Isomer 13 has a similar QY to
3 because of their structural similarity. However, isomers 4 and
14 have much higher QYs. As shown in Table 2, the QY of
compound 4 is 59.3, nearly five times larger than that of
compound 3. As for compound 14, the highest QY of 81.9 was
recorded. Since coumarins 3 and 4 (or 13 and 14) are quite
similar in their molecular structures, it is difficult to give a
rational explanation for the vast differences in the QYs. Further
studies are needed to explore the structure-property relationships
of such compounds.
Appendix A. Supplementary data
Supplementary data (general procedures, copies of NMR,
HRMS spectra, HPLC traces) to this article can be found online
at:
References and notes
1. Tyndall, S.; Wong, K. F.; VanAlstine-Parris, M. A. J. Org. Chem. 2015,
80, 8951-8953.
2. (a) Abdelhafez, O. M.; Amin, K. M.; Batran, R. Z.; Maher, T. J.; Nada,
S. A.; Sethumadhavan, S. Bioorg. Med. Chem. 2010, 18, 3371-3378; (b)
Lin, Y.; Shen, X.; Yuan, Q.; Yan, Y. Nat. Commun. 2013, 4, 2603.
3. Das, A. R.; Pal, G.; Bhattacharyya, P.; Ghosh, A. K.; Mukherjee, D.;
Bandyopadhyay, D. Tetrahedron. Lett. 2012, 53, 7060-7066.
4. (a) Emami, S.; Dadashpour, S. Eur. J. Med. Chem. 2015, 102, 611-630;
(b) Lingaraju, G. S.; Balaji, K. S.; Jayarama, S.; Anil, S. M.; Kiran, K.
R.; Sadashiva, M. P. Bioorg. Med. Chem. Lett. 2018, 28, 3606-3612.
5. Shaik, J. B.; Palaka, B. K.; Penumala, M.; Kotapati, K. V.; Devineni, S.
R.; Eadlapalli, S.; Darla, M. M.; Ampasala, D. R.; Vadde, R.; Amooru,
G. D. Eur. J. Med. Chem. 2016, 107, 219-232.
6. (a) Wu, M. Y.; Li, K.; Hou, J. T.; Huang, Z.; Yu, X. Q. Org. Biomol.
Chem. 2012, 10, 8342-8347; (b) Tan, L.; Lin, W.; Zhu, S.; Yuan, L.;
Zheng, K. Org. Biomol. Chem. 2014, 12, 4637-4643.
7. Cao, D.; Liu, Z.; Verwilst, P.; Koo, S.; Jangjili, P.; Kim, J. S.; Lin, W.
Chem. Rev. 2019, 119, 10403-10519.
8. (a) Bort, G.; Gallavardin, T.; Ogden, D.; Dalko, P. I. Angew. Chem. Int.
Ed. Engl. 2013, 52, 4526-4537; (b) Amatrudo, J. M.; Olson, J. P.; Lur,
G.; Chiu, C. Q.; Higley, M. J.; Ellis-Davies, G. C. R. ACS Chem.
Neurosci. 2014, 5, 64-70.
9. (a) Rwei. A. Y.; Zhan. C. Y.; Wang. B.; Kohane. D. S. J. Control.
Release. 2017, 251, 68–74; (b) Tamura, R.; Balabanova, A.; Frakes, S.
A.; Bargmann, A.; Grimm, J.; Koch, T. H.; Yin. H. J. Med. Chem. 2019,
62, 1959−1970.
10. Givens, R.; Matuszewski, B. J. Am. Chem. Soc. 1984, 106, 6860-6861.
11. Klán, P.; Šolomek, T.; Bochet, C. G.; Blanc, A.; Givens, R.; Rubina, M.;
Popik, V.; Kostikov, A.; Wirz, J. Chem. Rev. 2013, 113, 119-191.
12. Fournier, L.; Aujard, I.; Le Saux, T.; Maurin, S.; Beaupierre, S.; Baudin,
J. B.; Jullien, L. Chem. Eur. J. 2013, 19, 17494-17507.
13. (a) Soares, A. M. S.; Hungerford, G.; Costa, S. P. G.; Gonçalves, M. S.
T. New. J. Chem. 2015, 39, 7227-7233; (b) Soares, A. M. S.; Hungerford,
G.; Gonçalves, M. S. T.; Costa, S. P. G. New. J. Chem. 2017, 41, 2997-
3005; (c) Piloto, A. M.; Hungerford, G.; Costa, S. P. G.; Gonçalves, M.
S. T. Eur. J. Org. Chem. 2013, 34, 7715-7723.
14. Mattarei, A.; Romio, M.; Manago, A.; Zoratti, M.; Paradisi, C.; Szabo, I.;
Leanza, L.; Biasutto, L. Front. Oncol. 2018, 8, 122.
15. Symeonidis, T.; Fylaktakidou, K. C.; Hadjipavlou-Litina, D. J.; Litinas,
K. E. Eur. J. Med. Chem. 2009, 44, 5012-5017.